Target intelligence / Profile preview

Novel transcript, antisense to AKR1D1

Molecular classification: Long noncoding RNA (lncRNA), Antisense RNA

Overview

ENSG00000308006 is a long noncoding RNA (lncRNA) gene identified as a transcript antisense to the AKR1D1 gene, which itself encodes a steroid 5-beta-reductase. This locus is described in genomic databases as an intronic lncRNA overlapping the AKR1D1 coding region, and no protein product or established biological function has been reported. The transcript has not been characterized in terms of expression, function, disease association, or therapeutic relevance and lacks standardized nomenclature or aliases. Current information is limited to its genomic location and classification as an antisense lncRNA.

Beyond the preview

Go deeper on Novel transcript, antisense to AKR1D1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to AKR1D1.

Explore the full profile